Bexion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN), has appointed Tariq Arshad, MD, MBA as Chief Medical Officer.   Arshad is an oncologist with more than 25 years of experience and a successful track record of strategic planning, clinical development, and commercialization.   “We are thrilled to appoint Dr. Arshad as Bexion’s Chi...